跳至主要内容
临床试验/NL-OMON47598
NL-OMON47598撤回不适用

Adding rTMS to exposure therapy in PTSD in a placebo-controlled design : a pilot study - rTMS in PTSD

Radboud Universitair Medisch Centrum0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
撤回

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Based on cut-off scores and in line with previous studies, we will include 20 patients with a PTSD (minimum severity score of 50 on the the Clinician-Administered PTSD Scale, CAPS-1; Blake et al., 1995). All patients will receive intensive exposure therapy as part of their standard clinical treatment at the Centre of Anxiety Disorder in Overwaal. If patients reveal a suboptimal outcome and still have a minimum severity score of 50* as measured by clinician rated and self-rating lists- they will be offered to participate in the rTMS trial if they are eligible. Their standard treatment will be continued but monitored.

排除标准

  • With regard to transcranial brain stimulation
  • * Epilepsy, convulsion or seizure (TMS)
  • * Serious head trauma or brain surgery
  • * Large or ferromagnetic metal parts in the head (except for a dental wire)
  • * Implanted cardiac pacemaker or neurostimulator
  • * Pregnancy;With regard to general experimental requirements
  • * History or current presence of any neurologic or psychiatric disease other than PTSD and its affective comorbid disorders (including personality disorders)

研究者

相似试验